Home / MOTS : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MOTS make money? Does MOTS have pricing power? What's the Earnings Whisper? Will MOTS profit more as the business scales? What is MOTS's management track record? Is MOTS's current price justified?

Motus GI Holdings, Inc.

$0 +$0.00 (+100.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0.1

Market Cap

1.28K

AVG Volume

1.82K

Trailing/Forward PE

-0/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

Other OTC

Revenue (USD) · TTM

MOTS Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
24 Q1	327K
23 Q4	319K
23 Q3	364K
23 Q2	556K
23 Q1	628K
22 Q4	592K
22 Q3	582K
22 Q2	445K
22 Q1	360K
21 Q4	391K

Net Income (USD) · TTM

MOTS Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
24 Q1	-10.59M
23 Q4	-12.87M
23 Q3	-13.98M
23 Q2	-16.52M
23 Q1	-19.21M
22 Q4	-19.93M
22 Q3	-20.82M
22 Q2	-20.43M
22 Q1	-19.48M
21 Q4	-19.03M

Operating Income (USD) · TTM

MOTS Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
24 Q1	-9.57M
23 Q4	-11.91M
23 Q3	-13.46M
23 Q2	-15.77M
23 Q1	-17.68M
22 Q4	-17.85M
22 Q3	-18.38M
22 Q2	-18.01M
22 Q1	-18.01M
21 Q4	-17.92M

EBITDA (USD) · TTM

MOTS EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
24 Q1	-9.4M
23 Q4	-11.48M
23 Q3	-12.11M
23 Q2	-14.27M
23 Q1	-16.19M
22 Q4	-16.51M
22 Q3	-17.6M
22 Q2	-17.49M
22 Q1	-17.42M
21 Q4	-17.59M

Cash Flows (USD) · TTM

MOTS Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
24 Q1	-8.68M
23 Q4	-11.5M
23 Q3	-13.49M
23 Q2	-15.29M
23 Q1	-17.29M
22 Q4	-17.69M
22 Q3	-17.61M
22 Q2	-16.89M
22 Q1	-15.46M
21 Q4	-14.89M

EPS (USD) · TTM

MOTS EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
24 Q1	-12.92
23 Q4	-25.85
23 Q3	-36.69
23 Q2	-59.08
23 Q1	-84.05
22 Q4	-99.76
22 Q3	-117.03
22 Q2	-120.36
22 Q1	-119.24
21 Q4	-122.75

Expenses (USD) · TTM

MOTS Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
24 Q1	9.56M
23 Q4	11.76M
23 Q3	13.19M
23 Q2	15.8M
23 Q1	17.78M
22 Q4	17.87M
22 Q3	18.59M
22 Q2	17.91M
22 Q1	17.93M
21 Q4	18.16M

Shares Outstanding (USD) · TTM

MOTS Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
24 Q1	-308K
23 Q4	-459K
23 Q3	-808K
23 Q2	-1.2M
23 Q1	-1.68M
22 Q4	-2.03M
22 Q3	-2.35M
22 Q2	-2.76M
22 Q1	-3.31M
21 Q4	-3.71M

Employee Count

MOTS Employee Count by quarter
Period	Employee Count
2023	15
2022	43
2021	30
2020	24
2019	49
2018	44
2017	39

Free Cash Flow Yield

MOTS Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-503877.55%
Sep 26	-503877.54%
Aug 26	-1007755.1%
Aug 26	-1007755.1%
Aug 26	-1007755.1%
Aug 26	-1007755.1%
Jul 26	-1007755.07%
Jul 26	-1007755.1%
Jul 26	-1007755.1%
Jul 26	-1007755.1%
Jul 26	-1007755.07%
Jun 26	-1007755.1%
Jun 26	-1007755.1%
Jun 26	-1007755.07%
Jun 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
Apr 26	-1007755.1%
Apr 26	-1007755.1%
Apr 26	-1007755.1%
Apr 26	-1007755.1%
Mar 26	-1007755.1%
Mar 26	-1007755.1%
Mar 26	-1007755.1%
Mar 26	-1007755.1%
Feb 26	-1007755.07%
Feb 26	-503877.55%
Feb 26	-503877.55%
Feb 26	-1007755.1%
Jan 26	-1007755.1%
Jan 26	-100775507%
Jan 26	-1007755.1%
Jan 26	-1007755.1%
Jan 26	-1007755.1%
Dec 25	-1007755.07%
Dec 25	-1007755.1%
Dec 25	-1007755.1%
Dec 25	-1007755.1%
Nov 25	-1007755.07%
Nov 25	-503877.54%
Nov 25	-503877.54%
Nov 25	-1007755.1%
Oct 25	-1007755.1%
Oct 25	-503877.54%
Oct 25	-1007755.1%
Oct 25	-1007755.1%
Oct 25	-10077550.7%
Sep 25	-10077550.7%
Sep 25	-1007755.07%
Sep 25	-1007755.1%
Sep 25	-1007755.1%
Aug 25	-100775507%
Aug 25	-1007755.07%
Aug 25	-1007755.1%
Aug 25	-1007755.07%
Aug 25	-100775507%
Jul 25	-1007755.1%
Jul 25	-1007755.07%
Jul 25	-335918.34%
Jul 25	-335918.34%
Jun 25	-335918.34%
Jun 25	-335918.34%
Jun 25	-335918.34%
Jun 25	-335918.34%
May 25	-335918.34%
May 25	-335918.34%
May 25	-1007755.1%
May 25	-1007755.1%
May 25	-1007755.1%
Apr 25	-1007755.1%
Apr 25	-1007755.1%
Apr 25	-1007755.1%
Apr 25	-1007755.1%
Mar 25	-1007755.1%
Mar 25	-1007755.1%
Mar 25	-1007755.1%
Mar 25	-1007755.1%
Feb 25	-1007755.1%
Feb 25	-1007755.1%
Feb 25	-503877.55%
Feb 25	-503877.55%
Jan 25	-1007755.07%
Jan 25	-1007755.07%
Jan 25	-1007755.07%
Jan 25	-1007755.1%
Jan 25	-1007755.07%
Dec 24	-1007755.07%
Dec 24	-1007755.07%
Dec 24	-503877.54%
Dec 24	-251938.77%
Nov 24	-1007755.07%
Nov 24	-335918.36%
Nov 24	-251938.77%
Nov 24	-251938.77%
Nov 24	-100775.51%
Oct 24	-67183.67%
Oct 24	-80620.41%

Price to Sales

MOTS Price to Sales by quarter
Period	Price to Sales
Sep 26	0.01
Sep 26	0.01
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0
Jun 26	0
Jun 26	0
May 26	0
May 26	0
May 26	0
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0.01
Feb 26	0.01
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0.01
Nov 25	0.01
Nov 25	0
Oct 25	0
Oct 25	0.01
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0.01
Jul 25	0.01
Jun 25	0.01
Jun 25	0.01
Jun 25	0.01
Jun 25	0.01
May 25	0.01
May 25	0.01
May 25	0
May 25	0
May 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Feb 25	0
Feb 25	0
Feb 25	0.01
Feb 25	0.01
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Dec 24	0
Dec 24	0
Dec 24	0.01
Dec 24	0.01
Nov 24	0
Nov 24	0.01
Nov 24	0.01
Nov 24	0.01
Nov 24	0.03
Oct 24	0.04
Oct 24	0.03

Price to Book

MOTS Price to Book by quarter
Period	Price to Book
Sep 26	0
Sep 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0
Jun 26	0
Jun 26	0
May 26	0
May 26	0
May 26	0
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jun 25	0
Jun 25	0
Jun 25	0
Jun 25	0
May 25	0
May 25	0
May 25	0
May 25	0
May 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Feb 25	0
Feb 25	0
Feb 25	0
Feb 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Dec 24	0
Dec 24	0
Dec 24	0
Dec 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Oct 24	0
Oct 24	0

No video analysis for this stock yet. Request one from our team.

News: MOTS

accessnewswire.com · 28 Jul 2026

Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c

News Release Highlights: U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances. Vanta has established a strategic operating framework supporting its contemplated U.S. peptide platform, including telehealth-enabled commercialization, FDA-registered compounding pharmacy coordination, peptide manufacturing and fulfillment capabilities, and compliant payment processing infrastructure.

AI Analysis

Motus GI Holdings, Inc.

Video analysis: MOTS

News: MOTS

Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c

Similar companies